Celldex Therapeutics shares owned by SRS Capital Advisors
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by SRS Capital Advisors
from 13F filings
Historical chart of SRS Capital Advisors investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by SRS Capital Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Celldex Therapeutics by SRS Capital Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $4.7k | 139 | 33.99 |
2024-06-30 | $5.1k | 139 | 37.01 |